We are live on ! Find out more
NTUS

Natus Medical Inc

Delisted

NTUS was delisted on the 20th of July, 2022.

162 hedge funds and large institutions have $589M invested in Natus Medical Inc in 2013 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 57 increasing their positions, 51 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 10

154% more call options, than puts

Call options by funds: $6.84M | Put options by funds: $2.69M

59% more capital invested

Capital invested by funds: $372M → $589M (+$218M)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

22% more funds holding

Funds holding: 133162 (+29)

12% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 51

Holders
162
Holders Change
+29
Holders Change %
+21.8%
% of All Funds
4.7%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
40
Increased
57
Reduced
51
Closed
10
Calls
$6.84M
Puts
$2.69M
Net Calls
+$4.15M
Net Calls Change
+$4.65M
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
$5.6M +$171K +8,880 +4%
OAM
27
Oxford Asset Management
United Kingdom
$5.29M +$4.54M +235,067 New
Geode Capital Management
28
Geode Capital Management
Massachusetts
$4.71M +$1.31M +67,718 +48%
PCM
29
Penn Capital Management
Pennsylvania
$4.55M -$2.85M -147,323 -42%
QBFM
30
QS Batterymarch Financial Management
New York
$4.43M +$61.6K +3,190 +2%
BIM
31
Bogle Investment Management
Massachusetts
$4.42M +$3.79M +196,315 New
TCIM
32
TIAA CREF Investment Management
New York
$4.4M -$115K -5,935 -3%
Morgan Stanley
33
Morgan Stanley
New York
$4.17M +$872K +45,130 +32%
TI
34
Turner Investments
Pennsylvania
$4.12M +$3.54M +183,160 New
Principal Financial Group
35
Principal Financial Group
Iowa
$3.98M +$227K +11,748 +7%
RHJA
36
Rice Hall James & Associates
California
$3.98M -$158K -8,200 -4%
Renaissance Technologies
37
Renaissance Technologies
New York
$3.88M +$3.01M +156,000 +959%
Two Sigma Investments
38
Two Sigma Investments
New York
$3.54M +$2.62M +135,637 +631%
Invesco
39
Invesco
Georgia
$3.2M +$984K +50,955 +56%
IMOV
40
Investment Management of Virginia
Virginia
$3.11M +$535K +27,725 +25%
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$2.94M +$415K +21,490 +20%
AIS
42
AlphaOne Investment Services
Pennsylvania
$2.9M -$1.86M -96,080 -43%
Millennium Management
43
Millennium Management
New York
$2.88M +$1.35M +69,879 +120%
Ameriprise
44
Ameriprise
Minnesota
$2.71M +$283K +14,676 +14%
BIM
45
BlackRock Investment Management
Delaware
$2.39M -$48.4K -2,506 -2%
Jacobs Levy Equity Management
46
Jacobs Levy Equity Management
New Jersey
$2.22M -$463K -23,960 -20%
Prudential Financial
47
Prudential Financial
New Jersey
$2.18M -$34.8K -1,800 -2%
SKK
48
Shepherd Kaplan Krochuk
Massachusetts
$2.09M -$372K -19,277 -17%
GC
49
Guggenheim Capital
Illinois
$1.95M +$1.67M +86,719 New
SFM
50
Systematic Financial Management
New Jersey
$1.89M +$1.62M +83,970 New

NTUS Hedge Fund Activity: Q4 2013 in Review

162 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Natus Medical Inc (NTUS) for Q4 2013, worth a combined $589M — up 59% from $372M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new NTUS positions and 10 closed out — a net gain of 30 holders — while 57 added to existing stakes and 51 trimmed.

The largest buyer was Eagle Asset Management, adding an estimated $7.33M. The largest seller was Broadfin Capital, cutting an estimated $29.1M.

  • 162 institutional investors held Natus Medical Inc (NTUS) as of Q4 2013, up from 133 in Q3 2013.
  • Funds reported $589M of Natus Medical Inc stock for Q4 2013, up 59% quarter-over-quarter.
  • 40 funds opened new Natus Medical Inc positions in Q4 2013 and 10 closed out, a net change of +30 holders.
  • The largest Natus Medical Inc buyer in Q4 2013 was Eagle Asset Management, an estimated $7.33M added.
  • The largest Natus Medical Inc seller in Q4 2013 was Broadfin Capital, an estimated $29.1M sold.

Based on aggregated 13F filings for Q4 2013.